New designer proteins created using an AI tool can selectively target peptide segments that bind to markers on diseased ...

Aclaris Therapeutics announces positive top-line results from phase 2a clinical trial of ATI-2138: Wayne, Pennsylvania Friday, August 1, 2025, 14:00 Hrs [IST] Aclaris Therapeutics ...

AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard ...

David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...

Vir Biotech begins patient dosing in phase 1 trial of EGFR-targeting PRO-XTEN dual-masked T-cell engager VIR-5525 to treat solid tumours: San Francisco Saturday, July 26, 2025, 12 ...

Discover how lymphoid structures and germinal centers provide powerful prognostic insights into colorectal cancer.

The immune cell repertoire is composed of many different cell types that are orchestrated in response to infection and other ...

This review explores how NK cell senescence impacts cancer immunotherapy, highlighting key biomarkers like CD57 and reduced cytotoxicity. It reveals how the tumor microenvironment accelerates NK cell ...

Scientists create smart cells that administer automatic treatments from inside the human body, reacting within seconds to ...

A new study in cats with a fatal coronavirus infection suggests stem cell therapy could help tackle the immune damage behind ...

In a paper published in Science Bulletin, the research team led by Professor Wen Zhang from the Department of Rheumatology and Immunology at Peking Union Medical College Hospital (PUMCH) has made ...